Literature DB >> 8428754

Exclusion of two candidate pigment loci, c and b, part of chromosome 11p, and 33 random polymorphic markers as the locus for tyrosinase-positive oculocutaneous albinism.

M A Colman1, G Stevens, M Ramsay, B Kwon, T Jenkins.   

Abstract

The locus for Tyrosinase-Positive Oculocutaneous Albinism (ty-pos OCA) has not yet been localised. The search for the ty-pos OCA locus has included a search for linkage to candidate pigment loci and a candidate chromosomal region, as well as a random search using highly polymorphic markers in 42 families, including 271 individuals of whom 79 are affected. The lod scores for the tyrosinase (TYR) locus (11q14-q21), homologous to the albino locus, c, in the mouse and the CAS2/TRP1 locus (9p22-pter), homologous to the brown locus, b, in the mouse were -5.89 and -7.22, respectively, at a recombination fraction of theta = 0.01, thus excluding them from being the ty-pos OCA locus. In the candidate chromosomal region, 11p, four loci (probes) were tested, SAA (pSAA82), CALC (pHC36), HBB (Gamma-globin haplotype) and an AC repeat polymorphism at the Wilm's Tumour locus (WT1). A portion of 11p was excluded with the following lod scores: pSAA82 lod = -2.05 at theta = 0.10; pHC36 lod = -3.87 at theta = 0.05; gamma-globin haplotype lod = -2.80 at theta = 0.10; and WT1 lod = -2.34 at theta = 0.10. Thirty-three polymorphic markers randomly distributed on 13 different chromosomes were all excluded from close linkage to ty-pos OCA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428754     DOI: 10.1007/bf00217458

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  32 in total

1.  In quest of the tyrosinase-positive oculocutaneous albinism gene.

Authors:  T Jenkins; R A Heim; D S Dunn; E Zwane; M A Colman; M Ramsay; J G Kromberg
Journal:  Ophthalmic Paediatr Genet       Date:  1990-12

2.  Polymerase chain reaction for detection of the pMP6d-9/MspI RFLP, a marker closely linked to the cystic fibrosis mutation.

Authors:  A Huth; X Estivill; K Grade; H Billwitz; A Speer; A Rosenthal; R Williamson; M Ramsay; C Coutelle
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

3.  DNA in heritable disease.

Authors:  B C Sykes
Journal:  Lancet       Date:  1983-10-01       Impact factor: 79.321

4.  Allogenotypes defined by short DQ alpha and DQ beta cDNA probes correlate with and define splits of HLA-DQ serological specificities.

Authors:  J L Bidwell; E A Bidwell; G J Laundy; P T Klouda; B A Bradley
Journal:  Mol Immunol       Date:  1987-05       Impact factor: 4.407

5.  Mapping the human CAS2 gene, the homologue of the mouse brown (b) locus, to human chromosome 9p22-pter.

Authors:  C D Chintamaneni; M Ramsay; M A Colman; M F Fox; R T Pickard; B S Kwon
Journal:  Biochem Biophys Res Commun       Date:  1991-07-15       Impact factor: 3.575

6.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  The tyrosinase-related protein-1 gene has a structure and promoter sequence very different from tyrosinase.

Authors:  I J Jackson; D M Chambers; P S Budd; R Johnson
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

8.  RFLP for BgIII at the human tyrosinase (TYR) locus.

Authors:  R A Spritz; K M Strunk
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

Review 9.  Chromosome maps of man and mouse. IV.

Authors:  A G Searle; J Peters; M F Lyon; J G Hall; E P Evans; J H Edwards; V J Buckle
Journal:  Ann Hum Genet       Date:  1989-05       Impact factor: 1.670

10.  Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours.

Authors:  M H Little; R Dunn; J A Byrne; A Seawright; P J Smith; K Pritchard-Jones; V van Heyningen; N D Hastie
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.